Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase
90%
Enzyme Active Site
84%
P53
60%
Werner Syndrome
60%
Mosaicism
45%
Growth Factor Signaling
45%
Insulin Resistance
42%
Genetics
39%
Allele
36%
S Phase
34%
DNA Synthesis
34%
Genotyping
30%
DNA Polymerase Epsilon
30%
Mouse Model
30%
Polymerase
30%
Mammalian Target of Rapamycin
30%
Haplotype
30%
Low Drug Dose
30%
DNA Polymerase
30%
Replisome
30%
Drive
30%
Lymphocyte
30%
mTOR Signaling
30%
Prenatal Growth
30%
Cancer Cell
30%
Dysplasia
30%
Gain of Function Mutation
30%
Mitochondrial Dynamics
30%
Dyslipidemia
30%
Leptin
30%
Topoisomerase
30%
DNA Topoisomerase
30%
G2 Phase Cell Cycle Checkpoint
30%
Deep Sequencing
30%
Carcinogenesis
30%
Secretion (Process)
30%
Transcriptomics
30%
Protein Kinase B
30%
Mitochondrial Disorder
18%
Wild Type
15%
Helicase
15%
X Ray
15%
Sertraline
15%
Protein Kinase A
15%
MFN2
12%
Adiponectin
12%
Synapsin I
12%
Galactosidase
12%
Mitophagy
12%
Mitochondrion
12%
Protein Expression
12%
Mitochondrial Fusion
12%
Adipocyte
12%
Stem Cell
9%
Germ Layer
9%
Induced Pluripotent Stem Cell
9%
Homozygosity
9%
Upregulation
9%
Human Induced Pluripotent Stem Cell
9%
Telomere
8%
Exonuclease
7%
Exon
7%
Enzyme
7%
Body Height
7%
5-HT2B Receptor
7%
Exome
7%
Glucuronidation
7%
Phospholipid Metabolism
7%
Preclinical Study
6%
Morphology
6%
Metabolic Pathway
6%
Fat Mass
6%
Mitochondrial Fission
6%
Explant
6%
Insulin Analog
6%
Electron Microscopy
6%
Metabolic Disorder
6%
Body Weight
6%
Oxidative Phosphorylation
6%
Lipid Metabolism
6%
Small Interfering RNA
6%
Glucose Metabolism
6%
Cell Dedifferentiation
6%
Dynamin
6%
Mineralization
6%
Medicine and Dentistry
Insulin Resistance
100%
Diabetes
69%
Werner Syndrome
60%
Lipodystrophy
50%
Dyslipidemia
39%
Disease
39%
Malignant Neoplasm
36%
Immunosuppressive Treatment
35%
Adipose Tissue
30%
Prospective Cohort Study
30%
Bloom Syndrome
30%
Muscle Cramp
30%
mTOR Signaling
30%
Low Drug Dose
30%
Transcriptomics
30%
Rapamycin
30%
Breast Cancer
30%
Allogeneic Stem Cell Transplantation
30%
Adipocyte
30%
Spectrum Disorder
30%
Protein P53
30%
Human Pluripotent Stem Cell
30%
Mitochondrial Dynamics
30%
Vascular Smooth Muscle Cell
30%
Protein Kinase B
30%
Cellular Senescence
27%
Insulin Receptor
25%
Diseases
25%
Neoplasm
24%
Phosphoinositide 3-Kinase
23%
Paraprotein
22%
Capillary
20%
Precursor
20%
Macrocephaly
20%
Hemoglobin A1c
20%
Hyperandrogenism
20%
Autoantibody
20%
Enzyme Active Site
19%
Growth Factor
19%
Cancer Growth
15%
Growth Disorder
15%
Drug Repositioning
15%
Drive
15%
Mosaicism
14%
Fatty Liver
13%
Mitochondrial Fusion
12%
Synapsin I
12%
Protein Expression
12%
Mitophagy
12%
Galactosidase
12%
Hyperglycemia
9%
Malformation Syndrome
9%
Clinical Management
9%
Prematurity
9%
Embryonic Stem Cell
9%
Clustered Regularly Interspaced Short Palindromic Repeat
9%
Cas9
9%
Congenital Malformation
9%
Developmental Disorder
9%
DNA Repair
9%
Genome Editing
9%
Recurrent Disease
9%
Azathioprine
9%
Research Design
9%
Cyclophosphamide
9%
Rituximab
9%
Adipogenesis
9%
Mortality Rate
9%
Drug Megadose
9%
Positive Feedback
9%
Maintenance Therapy
9%
Short Stature
7%
Nonalcoholic Fatty Liver
7%
Exonuclease
7%
Molecular Diagnosis
7%
Primary Prevention
7%
Genetic Analysis
7%
Liver Fibrosis
7%
Premature Aging
7%
Helicase
7%
Complementary DNA
7%
Exome
7%
Smouldering Myeloma
7%
Exon
7%
Cell Dedifferentiation
6%
Breast Tumor
6%
Mitochondrial Fission
6%
Reactive Oxygen Species
6%
Optic Nerve Atrophy
6%
Mitochondrion
6%
Isotopes of Calcium
6%
Mineralization
6%
Dynamin
6%
Cellular Mechanism
6%
Artery Calcification
6%
Small Interfering RNA
6%
Cardiovascular Disease
6%
Cell Signaling Pathway
6%
Allele
6%
Treatment Effect
5%
Fulminant
5%
Allogeneic Peripheral Blood Stem Cell Transplantation
5%
Peripheral Blood Stem Cell Transplantation
5%
Immunology and Microbiology
Insulin Resistance
36%
DNA Polymerase
30%
G2 Phase Cell Cycle Checkpoint
30%
Cancer Cell
30%
Immunosuppressive Therapy
30%
Adipose Tissue
30%
Insulin
30%
P53
30%
Mouse Model
30%
Immunodeficiency
30%
Secretion (Process)
30%
Leptin
30%
DNA Synthesis
19%
Prenatal Growth
15%
Replisome
15%
Gain of Function Mutation
15%
Lymphocyte
15%
Autoantibodies
15%
Enzyme Active Site
15%
Insulin Receptor
15%
Haplotype
15%
Immune System Disorders
15%
Telomere
8%
Rituximab
7%
Drug Megadose
7%
Azathioprine
7%
Cyclophosphamide
7%
Mortality Rate
7%
Adipocyte
6%
Adiponectin
6%